LLM new ERA

Pharminicio, formerly known as Inkeysa, was originally established in 1980's and has a long-standing history in the pharmaceutical manufacturing sector. Over the years, the company has evolved from a local manufacturer into a modern, globally active organization. Pharminicio continues to build upon its strong industrial foundation, maintaining active involvement in strategic partnerships, collaborations, and investment initiatives that enhance its manufacturing capabilities and expand its international presence. These efforts reflect the company’s commitment to innovation, regulatory compliance, and sustainable growth.

Fostering strategic partnerships that promote efficiency, quality, and regulatory excellence. Through our experience in Loan Licensing Manufacturing (LLM), we collaborate with authorized manufacturing sites to ensure that pharmaceutical products are produced under full compliance with Good Manufacturing Practices (GMP) and national health authority requirements.

Our loan licensing model allows us to coordinate the manufacture, batch release, and quality assurance of products while maintaining clear regulatory accountability. Each activity is conducted under the respective licenses and authorizations of our partners, ensuring transparency and traceability at every stage of the process.

Pharminicio invests in manufacturing and quality-related activities, working closely with qualified manufacturers in Spain and other regions to support a compliant and flexible production network. These collaborations are structured to uphold the highest standards of quality, safety, and documentation integrity, ensuring that every product meets the expectations of both regulators and healthcare professionals.

Our commitment to excellence is reflected in every step — from product development and dossier preparation to batch release and logistics coordination. We continuously align with updated regulatory frameworks, ensuring our operations remain efficient, ethical, and transparent.